Aptys pharma

Founded in 2002, Aptys Pharma® is specialized in formulation design, pre-formulation and analytical development.

Aptys Pharma® also offers quality control and ICH stability studies thanks to its GMP-compliant and pre-qualified WHO laboratory.

Therefore, Aptys Pharma® clients can start GMP production thanks to a ready-to-use package covering the formula and recipe, the validated analytical methods and ICH stability data.

Aptys Pharma® proposes different consulting and operation services to its clients, to cover most strategic phases of drug development.

Our preformulation expertise is completed by our 2 offers: Soludiag® & Nanosolution® which have both the advantage to require low amounts of active substance and being fast.

Our formulation design expertise covers a wide range of dosage forms and particularly peptide-based forms (microspheres), buccal, ocular, transdermal, and injectable forms.

Since 2002, Aptys have developed numerous complex dosage forms. Such as Loramyc®, a sustained release bioadhesive buccal tablet containing miconazole to treat oral candidiasis, and Testocream®, a transdermal cream containing testosterone to treat hypogonadism.

Since 2017, Aptys Pharma® has been developing in partnership with Unither Pharmaceuticals an innovative combination of 2 analgesics dedicated to alleviating moderate to severe pain, currently in Phase III study.

Aptys Pharma® helps Its clients to go the GMP product. Our clients come to us because we can solve formulation problems and make from a bright idea an Industrial reality.

Moreover, Aptys Pharma® has strong expertise in the development of peptide-based products to assist their clients from the design of the peptide structure to the final dosage form.